Class III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents?
出版年份 2012 全文链接
标题
Class III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents?
作者
关键词
-
出版物
Expert Review of Anticancer Therapy
Volume 13, Issue 1, Pages 63-74
出版商
Informa UK Limited
发表日期
2012-12-22
DOI
10.1586/era.12.158
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Gender Influences the Class III and V -Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
- (2012) M. Mariani et al. CLINICAL CANCER RESEARCH
- Clear cell carcinoma of the ovary: A review of the literature
- (2012) Marcela G. del Carmen et al. GYNECOLOGIC ONCOLOGY
- Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer
- (2012) Nicoletta Colombo et al. JOURNAL OF CLINICAL ONCOLOGY
- Peloruside, Laulimalide, and Noscapine Interactions with Beta-Tubulin
- (2012) Melissa M. Gajewski et al. PHARMACEUTICAL RESEARCH
- Understanding the Basis of Drug Resistance of the Mutants of αβ-Tubulin Dimer via Molecular Dynamics Simulations
- (2012) Kathiresan Natarajan et al. PLoS One
- Clinical implications of REST and TUBB3 in ovarian cancer and its relationship to paclitaxel resistance
- (2012) Song Gao et al. TUMOR BIOLOGY
- Ixabepilone: Clinical Role in Metastatic Breast Cancer
- (2011) Neelima Denduluri et al. Clinical Breast Cancer
- Class III β -Tubulin (TUBB3): More than a Biomarker in Solid Tumors?
- (2011) M. Mariani et al. CURRENT MOLECULAR MEDICINE
- Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcoma cell lines is linked to tubulin-beta-III expression
- (2011) Luisa Carrara et al. GYNECOLOGIC ONCOLOGY
- Expression of ERCC1, p53, and Class III β-Tubulin Do Not Reveal Chemoresistance in Endometrial Cancer
- (2011) Ingrid Vandenput et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer
- (2011) Marta De Donato et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Neoadjuvant chemotherapy in ovarian, primary peritoneal and tubal carcinoma: can imaging results prior to interval debulking predict survival?
- (2011) Joseph Menczer et al. Journal of Gynecologic Oncology
- Potent Taccalonolides, AF and AJ, Inform Significant Structure–Activity Relationships and Tubulin as the Binding Site of These Microtubule Stabilizers
- (2011) Jing Li et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
- (2011) Sergio Marchini et al. LANCET ONCOLOGY
- Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression
- (2011) Stefania Nobili et al. MEDICINAL RESEARCH REVIEWS
- II-Tubulin and III-Tubulin Mediate Sensitivity to Peloruside A and Laulimalide, but not Paclitaxel or Vinblastine, in Human Ovarian Carcinoma Cells
- (2011) A. Kanakkanthara et al. MOLECULAR CANCER THERAPEUTICS
- Post-translational regulation of the microtubule cytoskeleton: mechanisms and functions
- (2011) Carsten Janke et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Epothilones: New Therapeutic Agents for Castration-Resistant Prostate Cancer
- (2011) T. B. Dorff et al. ONCOLOGIST
- The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
- (2010) S. Leskela et al. ENDOCRINE-RELATED CANCER
- Patupilone in cancer treatment
- (2010) Branislav Bystricky et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Ovarian and Uterine Carcinosarcomas
- (2010) Gunjal Garg et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Synergistic activity of ixabepilone plus other anticancer agents: preclinical and clinical evidence
- (2010) Francis Lee et al. Therapeutic Advances in Medical Oncology
- A mutation in β-tubulin and a sustained dependence on androgen receptor signalling in a newly established docetaxel-resistant prostate cancer cell line
- (2009) Takahito Hara et al. CELL BIOLOGY INTERNATIONAL
- Overexpression of Class III -Tubulin Predicts Good Response to Taxane-Based Chemotherapy in Ovarian Clear Cell Adenocarcinoma
- (2009) D. Aoki et al. CLINICAL CANCER RESEARCH
- Microtubule-severing enzymes
- (2009) Antonina Roll-Mecak et al. CURRENT OPINION IN CELL BIOLOGY
- A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers
- (2009) Divya Gupta et al. GYNECOLOGIC ONCOLOGY
- Safety and Efficacy of Patupilone in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer: A Phase I, Open-Label, Dose-Escalation Study
- (2009) Wim W. ten Bokkel Huinink et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P
- (2009) Don S. Dizon et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
- (2009) Koen De Geest et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of βIII tubulin in predicting chemoresistance in non-small cell lung cancer
- (2009) Pascal Sève et al. LUNG CANCER
- Ixabepilone: targeting III-tubulin expression in taxane-resistant malignancies
- (2009) C. Dumontet et al. MOLECULAR CANCER THERAPEUTICS
- Traffic control: regulation of kinesin motors
- (2009) Kristen J. Verhey et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- β3-Tubulin is induced by estradiol in human breast carcinoma cells through an estrogen-receptor dependent pathway
- (2009) Jennifer Saussede-Aim et al. CELL MOTILITY AND THE CYTOSKELETON
- A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
- (2008) William Schelman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Preclinical efficacy spectrum and pharmacokinetics of ixabepilone
- (2008) Francis Y. F. Lee et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Molecular Mechanisms of Patupilone Resistance
- (2008) S. Mozzetti et al. CANCER RESEARCH
- The Taccalonolides: Microtubule Stabilizers That Circumvent Clinically Relevant Taxane Resistance Mechanisms
- (2008) April L. Risinger et al. CANCER RESEARCH
- Synergistic Antitumor Activity of Ixabepilone (BMS-247550) Plus Bevacizumab in Multiple In vivo Tumor Models
- (2008) F. Y.F. Lee et al. CLINICAL CANCER RESEARCH
- A phase II evaluation of weekly docetaxel in the treatment of recurrent or persistent endometrial carcinoma: A study by the Gynecologic Oncology Group
- (2008) Agustin A. Garcia et al. GYNECOLOGIC ONCOLOGY
- Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?
- (2008) Pascal Sève et al. LANCET ONCOLOGY
- Conformational Analysis of the Carboxy-Terminal Tails of Human β-Tubulin Isotypes
- (2007) Tyler Luchko et al. BIOPHYSICAL JOURNAL
- Hypoxia induces class III beta-tubulin gene expression by HIF-1α binding to its 3' flanking region
- (2007) Giuseppina Raspaglio et al. GENE
- An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: A gynecologic oncology group study
- (2007) T.A. Grushko et al. GYNECOLOGIC ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started